Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gilead Sciences
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Body mass index (BMI) ≥ 18 kg/m\^2
HCV RNA ≥ 10000 IU/mL at screening
Prior treatment failure to a regimen including interferon with or without RBV
HCV genotype 1 or 3
Chronic HCV infection
Cirrhosis determination
Use of highly effective contraception methods if female of childbearing potential or sexually active male
You may not be if
Current or prior history of clinically significant illness other than HCV
Screening ECG with clinically significant abnormalities
Prior exposure to HCV specific direct acting antiviral agent
Pregnant or nursing female or male with pregnant female partner
Chronic liver disease of non-HCV etiology
Hepatitis B
Active drug abuse
Use of any prohibited concomitant medications
Clareo Health | Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection
